10028228 · Active · incorporated 10 years, 8 months ago · Oxford
Biotech Biotech & Life Sciences Drug Discovery Series B+
Omass Therapeutics Limited is a private limited company registered at Companies House under number 10028228, incorporated on 26 February 2016, with a registered office in Oxford. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 148 filings for this company, including 9 funding rounds. Its most recent round closed in July 2024, raising £34.2m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 9 | Jul 2024 | £34.2m | £1.71 |
| Round 8 | Apr 2023 | £6m | £1.71 |
| Round 7 | Apr 2022 | £53.3m | £1.71 |
| Round 6 | Aug 2021 | £8.5m | £1.30 |
| Round 5 | Oct 2020 | £3m | £1.30 |
| Round 4 | Feb 2020 | £8m | £1.30 |
Showing the 6 most recent of 9 rounds.
Showing the 10 most recent of 148 filings.
See the complete cap table with every shareholder, founder tags, dilution across 39 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.